Riverdale, NJ, United States of America

Jennifer Singelyn

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Riverdale, NJ (US) (2017 - 2019)
  • Morristown, NJ (US) (2021)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jennifer Singelyn

Introduction

Jennifer Singelyn is a dedicated inventor based in Riverdale, NJ, who has made significant contributions to the field of cardiac therapy through her innovative research and discoveries. With three patents to her name, her work focuses on compositions and methods that aim to repair and regenerate damaged cardiac tissues, marking her as a noteworthy figure in medical science.

Latest Patents

Jennifer's latest patents include groundbreaking work in tissue repair using extracellular matrices. One of her key patents, "Compositions and methods for tissue repair with extracellular matrices," describes compositions that comprise decellularized cardiac extracellular matrix and outlines various therapeutic uses. The methods she developed aim to treat, repair, or regenerate defective, diseased, damaged, or ischemic cells, tissues, or organs, particularly in human subjects. Another critical patent, titled "Compositions and methods for cardiac therapy," details methods and compositions designed to support tissue repair, focusing on extracellular-matrix-based products introduced to preserve and repair damaged heart tissue.

Career Highlights

Throughout her career, Jennifer has collaborated with esteemed institutions such as the University of California and Ventrix, Inc. Her work has positioned her at the forefront of cardiac research, where she has consistently contributed to advancements in therapeutic methods and techniques.

Collaborations

Jennifer has worked closely with her coworker, Jessica Dequach, in her research endeavors. Their collaboration has led to the development of innovative therapies that hold promise for many individuals suffering from cardiac issues.

Conclusion

In summary, Jennifer Singelyn has established herself as a prominent inventor in the field of cardiac therapy, with a commitment to developing methods and compositions that are crucial for tissue repair and regeneration. Her patents reflect her innovative spirit and dedication to improving healthcare outcomes for those in need of cardiac treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…